SUNPHARMA

launches alopecia drug Leqselvi in US after settling patent dispute

recieved approval from the US Food and Drug Administration for Leqselvi in July 2024. Soon after the regulator’s approval, Incyte Corporation filed a patent infringement lawsuit against Sun Pharma, alleging that Leqselvi infringed upon its existing patents.